Company registration number 09767951 (England and Wales)
HOMELINK HEALTHCARE LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
HOMELINK HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 8
HOMELINK HEALTHCARE LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
27,573
88,635
Current assets
Debtors
5
627,948
705,130
Cash at bank and in hand
1,412,632
1,015,458
2,040,580
1,720,588
Creditors: amounts falling due within one year
6
(526,316)
(985,262)
Net current assets
1,514,264
735,326
Total assets less current liabilities
1,541,837
823,961
Capital and reserves
Called up share capital
7
30,041
29,727
Share premium account
9,817,051
7,503,143
Profit and loss reserves
(8,305,255)
(6,708,909)
Total equity
1,541,837
823,961
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 7 October 2026 and are signed on its behalf by:
Mr S Walters
Director
Company Registration No. 09767951
HOMELINK HEALTHCARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
Share capital
Share premium account
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 January 2024
19,436
5,134,104
(5,077,716)
75,824
Year ended 31 December 2024:
Loss and total comprehensive income
-
-
(1,631,193)
(1,631,193)
Issue of share capital
7
10,291
2,369,039
-
2,379,330
Balance at 31 December 2024
29,727
7,503,143
(6,708,909)
823,961
Year ended 31 December 2025:
Loss and total comprehensive income
-
-
(1,596,346)
(1,596,346)
Issue of share capital
7
314
2,313,908
-
2,314,222
Balance at 31 December 2025
30,041
9,817,051
(8,305,255)
1,541,837
HOMELINK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information
Homelink Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is Mimet House, 5a Praed Street, London W2 1NJ.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
These financial statements are prepared on the going concern basis. Following an after-date investment, the directors have a reasonable expectation that the company has adequate resources trueto fulfil its financial obligations for a period of at least 12 months from the date of the accounts being signed.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Revenue from contracts for the provision of services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.
1.4
Intangible fixed assets other than goodwill
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Software
33% on cost
HOMELINK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Fixtures and fittings
33% on cost
Plant and machinery etc
33% on cost
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.6
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.7
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
HOMELINK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.8
Leases
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
2
Employees
The average number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
96
138
3
Intangible fixed assets
Other
£
Cost
At 1 January 2025 and 31 December 2025
8,394
Amortisation and impairment
At 1 January 2025 and 31 December 2025
8,394
Carrying amount
At 31 December 2025
At 31 December 2024
4
Tangible fixed assets
Fixtures and fittings
Computers
Total
£
£
£
Cost
At 1 January 2025
30,768
275,053
305,821
Additions
10,118
10,118
At 31 December 2025
30,768
285,171
315,939
Depreciation and impairment
At 1 January 2025
19,230
197,956
217,186
Depreciation charged in the year
10,256
60,924
71,180
At 31 December 2025
29,486
258,880
288,366
HOMELINK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
4
Tangible fixed assets
Fixtures and fittings
Computers
Total
£
£
£
(Continued)
- 6 -
Carrying amount
At 31 December 2025
1,282
26,291
27,573
At 31 December 2024
11,538
77,097
88,635
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
207,950
328,082
Other debtors
312,998
270,048
520,948
598,130
2025
2024
Amounts falling due after more than one year:
£
£
Corporation tax recoverable
27,000
27,000
Other debtors
80,000
80,000
107,000
107,000
Total debtors
627,948
705,130
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
112,560
128,934
Taxation and social security
100,453
122,523
Deferred income
77,690
428,113
Other creditors
99,102
124,085
Accruals and deferred income
136,511
181,607
526,316
985,262
HOMELINK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A Shares of 1p each
96,010
96,010
960
960
Ordinary A1 Shares of 1p each
72,872
72,872
729
729
Ordinary PP Shares of 1p each
2,803,750
2,803,750
28,038
28,038
Ordinary A2 Shares of 1p each
31,431
0
314
3,004,063
2,972,632
30,041
29,727
Ordinary A Shares: carry one vote per share and have rights to dividends after the payment of the preferential dividend on the Ordinary PP Shares and distributions after the Ordinary PP Shares, Ordinary A2 and A1 Shares return.
Ordinary A1 Shares: carry one vote per share and have rights to dividends after the payment of the preferential dividend on the Ordinary PP Shares and distributions after the Ordinary PP Shares and Ordinary A2 Shares return.
Ordinary A2 Shares: carry one vote per share and have rights to dividends after the payment of the preferential dividend on the Ordinary PP Shares and distributions after the Ordinary PP Shares return.
Ordinary PP Shares: carry no voting rights, but do have rights to a non-cumulative cash preferential dividend of 8% of their issue price and on a sale they rank ahead to receive 16% of their issue price plus any arrears of their preferential dividends, plus their issue price.
8
Audit report information
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.
The auditor's report is unqualified and includes the following:
Opinion
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
Senior Statutory Auditor:
Jack Tatschner ACA
Statutory Auditor:
Azets Audit Services
Date of audit report:
8 October 2026
9
Operating lease commitments
As lessee
HOMELINK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
9
Operating lease commitments
(Continued)
- 8 -
At the balance sheet date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2025
2024
£
£
Total commitments
160,440
80,879
10
Events after the reporting date
On 7 October 2026, the Company raised £1,299,994 from its private equity investors and £278,388 from other shareholders.
11
Related-party transactions
At the year end there was a loan due from Jill Ireland, a Director of the Company, of £80,000 (2024: £80,000). The loan attracts an interest rate of 0.5% above the HMRC official rate of interest. The interest element is due for repayment each year by 5 July following the balance sheet date. The capital element is due for repayment five years after it was drawn. The amount of interest accrued in the year totalled £2,837 (2024: £1,652).
2025-12-312025-01-01falsefalsefalse08 October 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr A ReevesMs J IrelandMr S WaltersMr J BereikaMr D LomaxMr N MettyearMr S Walters097679512025-01-012025-12-31097679512025-12-31097679512024-12-3109767951core:FurnitureFittings2025-12-3109767951core:ComputerEquipment2025-12-3109767951core:FurnitureFittings2024-12-3109767951core:ComputerEquipment2024-12-3109767951core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3109767951core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3109767951core:Non-currentFinancialInstrumentscore:AfterOneYear2025-12-3109767951core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3109767951core:ShareCapital2025-12-3109767951core:ShareCapital2024-12-3109767951core:SharePremium2025-12-3109767951core:SharePremium2024-12-3109767951core:RetainedEarningsAccumulatedLosses2025-12-3109767951core:RetainedEarningsAccumulatedLosses2024-12-3109767951core:ShareCapital2023-12-3109767951core:SharePremium2023-12-3109767951core:RetainedEarningsAccumulatedLosses2023-12-3109767951core:ShareCapitalOrdinaryShareClass12025-12-3109767951core:ShareCapitalOrdinaryShareClass12024-12-3109767951core:ShareCapitalOrdinaryShareClass32025-12-3109767951core:ShareCapitalOrdinaryShareClass32024-12-3109767951core:ShareCapitalOrdinaryShareClass42025-12-3109767951core:ShareCapitalOrdinaryShareClass42024-12-3109767951core:ShareCapitalOrdinaryShareClass52025-12-3109767951core:ShareCapitalOrdinaryShareClass52024-12-3109767951core:ShareCapitalOrdinaryShares2025-12-3109767951core:ShareCapitalOrdinaryShares2024-12-3109767951bus:CompanySecretaryDirector12025-01-012025-12-3109767951core:RetainedEarningsAccumulatedLosses2024-01-012024-12-31097679512024-01-012024-12-3109767951core:RetainedEarningsAccumulatedLosses2025-01-012025-12-3109767951core:ShareCapital2024-01-012024-12-3109767951core:SharePremium2024-01-012024-12-3109767951core:ShareCapital2025-01-012025-12-3109767951core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3109767951core:FurnitureFittings2025-01-012025-12-3109767951core:ComputerEquipment2025-01-012025-12-3109767951core:IntangibleAssetsOtherThanGoodwill2024-12-3109767951core:IntangibleAssetsOtherThanGoodwill2025-12-3109767951core:IntangibleAssetsOtherThanGoodwill2024-12-3109767951core:FurnitureFittings2024-12-3109767951core:ComputerEquipment2024-12-31097679512024-12-3109767951core:CurrentFinancialInstruments2025-12-3109767951core:CurrentFinancialInstruments2024-12-3109767951core:Non-currentFinancialInstruments2025-12-3109767951core:Non-currentFinancialInstruments2024-12-3109767951bus:OrdinaryShareClass12025-01-012025-12-3109767951bus:OrdinaryShareClass32025-01-012025-12-3109767951bus:OrdinaryShareClass42025-01-012025-12-3109767951bus:OrdinaryShareClass52025-01-012025-12-3109767951bus:OrdinaryShareClass12025-12-3109767951bus:OrdinaryShareClass12024-12-3109767951bus:OrdinaryShareClass32025-12-3109767951bus:OrdinaryShareClass32024-12-3109767951bus:OrdinaryShareClass42025-12-3109767951bus:OrdinaryShareClass42024-12-3109767951bus:OrdinaryShareClass52025-12-3109767951bus:OrdinaryShareClass52024-12-3109767951bus:AllOrdinaryShares2025-12-3109767951bus:AllOrdinaryShares2024-12-3109767951bus:PrivateLimitedCompanyLtd2025-01-012025-12-3109767951bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3109767951bus:FRS1022025-01-012025-12-3109767951bus:Audited2025-01-012025-12-3109767951bus:Director12025-01-012025-12-3109767951bus:Director22025-01-012025-12-3109767951bus:Director32025-01-012025-12-3109767951bus:Director42025-01-012025-12-3109767951bus:Director52025-01-012025-12-3109767951bus:Director62025-01-012025-12-3109767951bus:CompanySecretary12025-01-012025-12-3109767951bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP